Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Apr;38(4):385-386.
doi: 10.1007/s40261-018-0628-2.

Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?

Alain Braillon  1 , Francoise Taiebi  2   3 , Amal Bernoussi  3
Affiliations
Comment

Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?

Alain Braillon et al. Clin Drug Investig. 2018 Apr.
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Barrio P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A. Who receives nalmefene and how does it work in the real world? A single-arm, Phase IV study of nalmefene in alcohol dependent outpatients: baseline and 1-month results. Clin Drug Investig. 2017. https://doi.org/10.1007/s40261-017-0590-4 .
    1. National Institute for Health and Care Excellence. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence. 2011. https://www.nice.org.uk/guidance/cg115/chapter/1-Guidance .
    1. Braillon A. Nalmefene in alcohol misuse: junk evaluation by the European Medicines Agency. BMJ. 2014;348:g2017. - DOI - PubMed
    1. Spence D. Bad medicine: nalmefene in alcohol misuse. BMJ. 2014;348:g1531. - DOI - PubMed
    1. Stevenson M, Pandor A, Stevens JW, Rawdin A, Rice P, Thompson J, Morgan MY. Nalmefene for reducing alcohol consumption in people with alcohol dependence: an evidence review group perspective of a NICE single technology appraisal. Pharmacoeconomics. 2015;33:833–47. - DOI - PubMed

LinkOut - more resources